We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
-15.9%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$2.49B
AUM Growth
-$656M
Cap. Flow
-$84.6M
Cap. Flow %
-3.39%
Top 10 Hldgs %
39.14%
Holding
242
New
12
Increased
27
Reduced
100
Closed
17

Top Buys

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$27M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$10.1M
3
WAT icon
Waters Corp
WAT
+$6.41M
4
EPD icon
Enterprise Products Partners
EPD
+$3.16M
5
LH icon
Labcorp
LH
+$3.14M

Top Sells

Rank Stock Value
1
MDR
McDermott International
MDR
+$30.5M
2
SLB icon
SLB Ltd
SLB
+$24.4M
3
LBTYA icon
Liberty Global Class A
LBTYA
+$12.9M
4
QCOM icon
Qualcomm
QCOM
+$11.1M
5
MSFT icon
Microsoft
MSFT
+$7.5M

Sector Composition

Rank Sector Weight
1 Financials 30.05%
2 Healthcare 18.3%
3 Technology 12.11%
4 Communication Services 10.64%
5 Industrials 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMB icon
51
Kimberly-Clark
KMB
$37.6B
$8.48M 0.34%
74,455
-1,300
-2% -$144K
HUBB icon
52
Hubbell
HUBB
$24.4B
$8.41M 0.34%
84,642
-3,264
-4% -$358K
LBTYA icon
53
Liberty Global Class A
LBTYA
$3.59B
$7.57M 0.3%
354,724
-525,321
-60% -$12.9M
PG icon
54
Procter & Gamble
PG
$340B
$7.42M 0.3%
80,770
-7,686
-9% -$687K
OAK
55
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$7.14M 0.29%
179,676
-97,049
-35% -$3.99M
SLB icon
56
SLB Ltd
SLB
$72.7B
$6.97M 0.28%
193,152
-495,343
-72% -$24.4M
AAPL icon
57
Apple
AAPL
$4.97T
$6.3M 0.25%
159,880
-500
-0.3% -$24.2K
COP icon
58
ConocoPhillips
COP
$144B
$6.12M 0.25%
98,220
-11,911
-11% -$810K
ABBV icon
59
AbbVie
ABBV
$465B
$5.72M 0.23%
62,097
-1,360
-2% -$120K
RDNT icon
60
RadNet
RDNT
$4.98B
$5.48M 0.22%
538,903
+23,383
+5% +$318K
BRK.A icon
61
Berkshire Hathaway Class A
BRK.A
$1.1T
$5.2M 0.21%
17
– –
CVX icon
62
Chevron
CVX
$382B
$4.77M 0.19%
43,881
-2,310
-5% -$268K
FISV
63
Fiserv Inc
FISV
$29.7B
$4.3M 0.17%
58,484
-2,346
-4% -$181K
PFE icon
64
Pfizer
PFE
$143B
$4.22M 0.17%
101,846
– –
HD icon
65
Home Depot
HD
$337B
$3.82M 0.15%
22,233
– –
AZO icon
66
AutoZone
AZO
$51.3B
$3.77M 0.15%
4,500
– –
MMM icon
67
3M
MMM
$91.8B
$3.45M 0.14%
21,681
-799
-4% -$133K
CL icon
68
Colgate-Palmolive
CL
$74.8B
$2.98M 0.12%
50,059
-3,600
-7% -$225K
KO icon
69
Coca-Cola
KO
$383B
$2.85M 0.11%
60,207
-9,801
-14% -$469K
BA icon
70
Boeing
BA
$169B
$2.81M 0.11%
8,703
-66
-0.8% -$22.8K
PEP icon
71
PepsiCo
PEP
$196B
$2.69M 0.11%
24,306
-1,279
-5% -$144K
AJG icon
72
Arthur J. Gallagher & Co
AJG
$69.1B
$2.65M 0.11%
36,000
– –
TV icon
73
Televisa
TV
$1.49B
$2.48M 0.1%
197,381
-12,150
-6% -$178K
COST icon
74
Costco
COST
$432B
$2.44M 0.1%
11,965
-695
-5% -$155K
RTX icon
75
RTX Corp
RTX
$290B
$2.38M 0.1%
35,587
-2,366
-6% -$186K
1 2
3
4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q4 2018 Portfolio in Review

As of Q4 2018, Beck Mack & Oliver held 242 positions worth $2.49B, down 21% from $3.15B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Beck Mack & Oliver withdrew a net $84.6M in Q4 2018, closing 17 positions and reducing 100 holdings. Its most notable exit was McDermott International, an estimated $30.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Beck Mack & Oliver opened a new position in Sherwin-Williams worth $26.3M.

  • Beck Mack & Oliver's largest Q4 2018 buy was Sherwin-Williams: 200,220 shares worth $26.3M.
  • Beck Mack & Oliver added most to Teva Pharmaceuticals in Q4 2018, an estimated $10.1M increase.
  • Beck Mack & Oliver's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $24.4M.
  • Beck Mack & Oliver fully exited McDermott International in Q4 2018, selling an estimated $30.5M.
  • Beck Mack & Oliver's ten largest holdings make up 39% of its $2.49B portfolio in Q4 2018.
  • Beck Mack & Oliver opened 12 new positions and closed 17 in Q4 2018.
  • Beck Mack & Oliver's portfolio value fell 21% quarter-over-quarter to $2.49B.

Based on Beck Mack & Oliver's 13F filing for Q4 2018, filed 4 Feb 2019.